molybdenum has been researched along with Alveolitis, Fibrosing in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, X; Guo, H; Hu, Z; Huang, G; Luo, J; Pu, W; Wang, X; Zhang, C | 1 |
| Ovet, H; Oztay, F | 1 |
| Brewer, GJ; Dick, R; Olivarez, L; Phan, SH; Ullenbruch, MR | 1 |
| Flaherty, KR; Lynch, JP; Martinez, FJ; Thannickal, VJ | 1 |
| Brewer, GJ; Dick, R; Jin, H; Phan, SH; Ullenbruch, MR | 1 |
| Allen, J; Baran, CP; Bhatt, N; Magro, C; Marsh, CB | 1 |
| Brakhnova, IT; Samsonov, GV | 1 |
2 review(s) available for molybdenum and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Connective Tissue Growth Factor; Eicosanoids; Endothelin-1; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Molybdenum; Protein Kinase Inhibitors; Proteins; Pulmonary Fibrosis; Pyridones; Recombinant Proteins; Relaxin; Renin-Angiotensin System; Tumor Necrosis Factor-alpha | 2004 |
Promising pharmacologic innovations in treating pulmonary fibrosis.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antioxidants; Connective Tissue Growth Factor; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lung; Molybdenum; Neovascularization, Pathologic; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic | 2006 |
5 other study(ies) available for molybdenum and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Molybdenum and cadmium co-exposure promotes M1 macrophage polarization through oxidative stress-mediated inflammatory response and induces pulmonary fibrosis in Shaoxing ducks (Anas platyrhyncha).
Topics: Animals; Cadmium; Ducks; Macrophages; Molybdenum; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pulmonary Fibrosis; Toll-Like Receptor 4; Transforming Growth Factor beta1 | 2022 |
The copper chelator tetrathiomolybdate regressed bleomycin-induced pulmonary fibrosis in mice, by reducing lysyl oxidase expressions.
Topics: Animals; Bleomycin; Chelating Agents; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 8; Mice; Mice, Inbred C57BL; Molybdenum; Protein-Lysine 6-Oxidase; Pulmonary Fibrosis | 2014 |
Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Bleomycin; Body Weight; Ceruloplasmin; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hydroxyproline; Lung; Mice; Mice, Inbred CBA; Molybdenum; Pulmonary Fibrosis | 2003 |
Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Bleomycin; Ceruloplasmin; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Lung; Mice; Mice, Inbred CBA; Molybdenum; Pulmonary Fibrosis; Time Factors | 2004 |
[Comparative assessment of the effect on the organism of silicides of the transitional metals].
Topics: Animals; Molybdenum; Pulmonary Fibrosis; Rats; Silicon; Titanium; Tungsten | 1970 |